Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors
US11524963B2 · kind B2 · utility
0Cited by
82References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 18, 2019 |
| Grant date | Dec 13, 2022 |
| Priority date | — |
| Expiry date | May 22, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds of the Formula I: and tautomers and pharmaceutically acceptable salts and solvates thereof, wherein R1 and R2 have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.